ROME — In this Healio Video Perspective from the FLORetina-ICOOR meeting, Jean-François Korobelnik, MD, PhD, reflects on how retina specialists are going to use high-dose aflibercept in real-world practice.
“We have to think about strategies besides the results of the randomized clinical trials,” he said, posing a few questions that will be answered with clinical experience.